For America’s politicians, there are few simpler bogeymen to rail in opposition to than pharma bosses. Solely a fifth of the nation has a constructive opinion of the trade, in response to Gallup, a pollster—which means its executives rank beneath even property brokers within the public’s esteem. The attention-watering costs of many medication in America have created the impression of a grasping trade that exploits the sick.
